CLINICAL_TRIALS
withdrawal
· 2012-08-31
Clinical Trial Update: Chondroitin Sulfate for Crohn's Disease [Phase 1, Phase 2]
Summary
A Phase 1/2 clinical trial evaluating chondroitin sulfate for Crohn's disease was withdrawn.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University Hospitals Cleveland Medical Center | Conditions: Crohn's Disease | Phase 1, Phase 2 | Status: WITHDRAWN